February 11, 2010
|
Roche Diabetes Candidate Meets Goals of Five Trials
BusinessWeek 11 (Bloomberg) — Roche Holding AG said results from five late-stage clinical trials show that its experimental diabetes drug taspoglutide reduced blood … Roche diabetes drug cuts blood sugar in 5 studies Reuters Roche Diabetes Treatment Drug Release Has Less Risks HULIQ Roche diabetes drug performs like a blockbuster in Ph3 FierceBiotech Zenopa - Pharma Times - Easy Bourse all 20 news articles » |
Filed under News and Info by on Feb 11th, 2010. Comment. 
|
Roche diabetes drug cuts blood sugar in 5 studies
Reuters ZURICH, Feb 11 (Reuters) – A weekly diabetes drug from Roche (ROG.VX) reduced blood sugar compared with other treatments across five late-stage clinical … Roche’s Experimental Diabetes Drug Meets Study Goals Easy Bourse Roche drug may offer valuable new treatment option for patients with type 2 … A Sweet Life (blog) Roche: Taspoglutide Meets Goals In Five Late-Stage Trials Easy Bourse |
Filed under News and Info by on Feb 11th, 2010. Comment.
December 31, 2009
 TopNews United States |
Biodel shares up on diabetes drug marketing application
Reuters O) shares rose as much as 27 percent Thursday, a day after the company filed for marketing approval for its experimental diabetes drug VIAject. … Biodel Seeks FDA Approval Of VIAject For Diabetes Treatment Wall Street Journal Biodel Submits Viaject New Diabetes Drug For FDA Approval Visit Bulgaria Biodel Submits VIAject New Drug Application To FDA For Treatment Of Diabetes … RTT News MSN Money - Earthtimes (press release) - StreetInsider.com (subscription) all 33 news articles » |
Filed under News and Info by on Dec 31st, 2009. Comment.
TopNews United States |
Biodel submits NDA for diabetes drug to FDA
Reuters O) said it submitted a new drug application to US health regulators for its experimental diabetes drug VIAject, sending its shares up 12 percent in … Biodel Seeks FDA Approval Of VIAject For Diabetes Treatment Wall Street Journal Biodel Submits VIAject New Drug Application To FDA For Treatment Of Diabetes … RTT News Biodel Submits VIAject® New Drug Application to FDA for Treatment of Diabetes Earthtimes (press release) MSN Money - TopNews United States - Pharmaceutical Business Review all 21 news articles » |
Filed under News and Info by on Dec 31st, 2009. Comment.
December 3, 2009
|
Roche Says Diabetes Drug Better Than Merck Januvia
Wall Street Journal VX) said Wednesday an experimental once-weekly treatment under development works better in treating a type of diabetes than Merck & Co. … UPDATE 1-Roche-licensed diabetes drug meets trial targets Reuters Roche’s diabetes drug tops rival Januvia Pharma Times Roche Claims its Experimental Diabetes Drug as Better than Merck’s Januvia TopNews United States Daily Finance (blog) - FierceBiotech - Minyanville.com all 43 news articles » |
Filed under News and Info by on Dec 3rd, 2009. Comment.